Axa’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-456,666
| Closed | -$16.6M | – | 820 |
|
|
2025
Q2 | $16.6M | Buy |
456,666
+371
| +0.1% | +$13.4K | 0.05% | 310 |
|
|
2025
Q1 | $16.5M | Sell |
456,295
-293
| -0.1% | -$12.2K | 0.05% | 303 |
|
|
2024
Q4 | $19.2M | Buy |
456,588
+31,198
| +7% | +$1.55M | 0.06% | 283 |
|
|
2024
Q3 | $23.6M | Buy |
425,390
+56
| +0% | +$2.85K | 0.07% | 247 |
|
|
2024
Q2 | $17.5M | Buy |
425,334
+92,567
| +28% | +$3.95M | 0.05% | 289 |
|
|
2024
Q1 | $15.5M | Buy |
332,767
+55
| +0% | +$2.59K | 0.05% | 324 |
|
|
2023
Q4 | $15.9M | Sell |
332,712
-11,787
| -3% | -$457K | 0.05% | 311 |
|
|
2023
Q3 | $12.3M | Sell |
344,499
-721
| -0.2% | -$28.6K | 0.04% | 358 |
|
|
2023
Q2 | $15.9M | Buy |
345,220
+24,199
| +8% | +$1.12M | 0.05% | 323 |
|
|
2023
Q1 | $12.9M | Sell |
321,021
-412
| -0.1% | -$17.7K | 0.04% | 367 |
|
|
2022
Q4 | $14.9M | Sell |
321,433
-966
| -0.3% | -$38K | 0.05% | 357 |
|
|
2022
Q3 | $13.4M | Buy |
322,399
+96,761
| +43% | +$4.97M | 0.05% | 369 |
|
|
2022
Q2 | $13.5M | Sell |
225,638
-2,415
| -1% | -$149K | 0.05% | 374 |
|
|
2022
Q1 | $16.6M | Sell |
228,053
-1,716
| -0.7% | -$119K | 0.05% | 394 |
|
|
2021
Q4 | $19.3M | Buy |
229,769
+11,056
| +5% | +$900K | 0.05% | 366 |
|
|
2021
Q3 | $19.7M | Buy |
218,713
+29,735
| +16% | +$2.69M | 0.06% | 338 |
|
|
2021
Q2 | $18M | Buy |
188,978
+44,223
| +31% | +$4.61M | 0.05% | 376 |
|
|
2021
Q1 | $16.5M | Sell |
144,755
-18,519
| -11% | -$2.52M | 0.05% | 394 |
|
|
2020
Q4 | $22.6M | Sell |
163,274
-63,323
| -28% | -$7.51M | 0.07% | 305 |
|
|
2020
Q3 | $18.6M | Sell |
226,597
-511
| -0.2% | -$42.4K | 0.07% | 301 |
|
|
2020
Q2 | $17.8M | Sell |
227,108
-69,509
| -23% | -$4.6M | 0.07% | 291 |
|
|
2020
Q1 | $13.2M | Sell |
296,617
-73,145
| -20% | -$3.8M | 0.07% | 301 |
|
|
2019
Q4 | $15.8M | Buy |
369,762
+40,407
| +12% | +$1.67M | 0.06% | 345 |
|
|
2019
Q3 | $14.1M | Buy |
329,355
+32,364
| +11% | +$1.76M | 0.06% | 375 |
|
|
2019
Q2 | $18.9M | Buy |
296,991
+3,601
| +1% | +$229K | 0.07% | 314 |
|
|
2019
Q1 | $20.4M | Buy |
293,390
+117,365
| +67% | +$6.71M | 0.08% | 301 |
|
|
2018
Q4 | $7.65M | Buy |
176,025
+81,242
| +86% | +$4.44M | 0.03% | 490 |
|
|
2018
Q3 | $7.24M | Sell |
94,783
-102,720
| -52% | -$8.35M | 0.03% | 567 |
|
|
2018
Q2 | $15.2M | Sell |
197,503
-66,612
| -25% | -$4.3M | 0.06% | 339 |
|
|
2018
Q1 | $13.5M | Sell |
264,115
-1,905
| -0.7% | -$95.9K | 0.05% | 366 |
|
|
2017
Q4 | $12.3M | Buy |
266,020
+612
| +0.2% | +$30K | 0.05% | 399 |
|
|
2017
Q3 | $14.1M | Buy |
265,408
+28,755
| +12% | +$1.7M | 0.06% | 345 |
|
|
2017
Q2 | $14.7M | Buy |
236,653
+70,968
| +43% | +$4.28M | 0.07% | 332 |
|
|
2017
Q1 | $11.2M | Sell |
165,685
-70,782
| -30% | -$5.39M | 0.05% | 387 |
|
|
2016
Q4 | $16.6M | Buy |
236,467
+2,898
| +1% | +$206K | 0.08% | 289 |
|
|
2016
Q3 | $16.6M | Buy |
233,569
+6,356
| +3% | +$406K | 0.07% | 288 |
|
|
2016
Q2 | $11.1M | Sell |
227,213
-19,786
| -8% | -$1.28M | 0.05% | 366 |
|
|
2016
Q1 | $15.6M | Sell |
246,999
-2,949
| -1% | -$193K | 0.07% | 307 |
|
|
2015
Q4 | $28M | Buy |
249,948
+118,750
| +91% | +$11.9M | 0.12% | 217 |
|
|
2015
Q3 | $12.6M | Buy |
131,198
+15,546
| +13% | +$1.78M | 0.05% | 325 |
|
|
2015
Q2 | $11.8M | Buy |
115,652
+676
| +0.6% | +$52.5K | 0.05% | 383 |
|
|
2015
Q1 | $7.14M | Buy |
114,976
+52,766
| +85% | +$2.93M | 0.03% | 485 |
|
|
2014
Q4 | $2.73M | Buy |
62,210
+199
| +0.3% | +$9.12K | 0.01% | 714 |
|
|
2014
Q3 | $3.51M | Buy |
62,011
+41,159
| +197% | +$2.07M | 0.02% | 612 |
|
|
2014
Q2 | $936K | Hold |
20,852
| – | – | ﹤0.01% | 951 |
|
|
2014
Q1 | $1.02M | Buy |
+20,852
| New | +$1.07M | ﹤0.01% | 917 |
|
Other funds holding RARE
RI
BBA
